NasdaqCM - Delayed Quote USD

Palisade Bio, Inc. (PALI)

5.16 0.00 (0.00%)
At close: 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
250.00
--
--
--
Operating Expense
13,989.00
13,095.00
15,311.00
11,737.00
9,297.00
Operating Income
-13,989.00
-12,845.00
-15,311.00
-11,737.00
-9,297.00
Net Non Operating Interest Income Expense
-16.00
-15.00
-13.00
-3,084.00
-1,076.00
Other Income Expense
518.00
560.00
1,064.00
-11,795.00
51.00
Pretax Income
-13,487.00
-12,300.00
-14,260.00
-26,616.00
-10,322.00
Net Income Common Stockholders
-13,503.00
-12,316.00
-14,548.00
-26,616.00
-10,322.00
Average Dilution Earnings
--
--
--
-5,119.00
--
Diluted NI Available to Com Stockholders
-13,503.00
-12,316.00
-14,548.00
-31,735.00
-10,322.00
Basic EPS
-23.46
-27.00
-247.95
-2.14k
-2.79k
Diluted EPS
-23.46
-27.00
-247.95
-2.55k
-2.79k
Basic Average Shares
576.12
456.01
58.69
12.41
3.70
Diluted Average Shares
576.12
456.01
58.69
12.46
3.70
Total Operating Income as Reported
-14,214.00
-13,070.00
-15,721.00
-41,854.00
-9,297.00
Total Expenses
13,989.00
13,095.00
15,311.00
11,737.00
9,297.00
Net Income from Continuing & Discontinued Operation
-13,487.00
-12,300.00
-14,260.00
-26,616.00
-10,322.00
Normalized Income
-13,262.00
-12,075.00
-12,740.00
-16,564.00
-10,360.00
Interest Expense
16.00
15.00
13.00
2,398.00
235.00
Net Interest Income
-16.00
-15.00
-13.00
-3,084.00
-1,076.00
EBIT
-13,471.00
-12,285.00
-14,247.00
-24,218.00
-10,087.00
EBITDA
-13,467.00
-12,281.00
-14,244.00
-24,216.00
-10,084.00
Reconciled Depreciation
4.00
4.00
3.00
2.00
3.00
Net Income from Continuing Operation Net Minority Interest
-13,487.00
-12,300.00
-14,260.00
-26,616.00
-10,322.00
Total Unusual Items Excluding Goodwill
-225.00
-225.00
-1,520.00
-10,052.00
38.00
Total Unusual Items
-225.00
-225.00
-1,520.00
-10,052.00
38.00
Normalized EBITDA
-13,242.00
-12,056.00
-12,724.00
-14,164.00
-10,122.00
12/31/2020 - 3/30/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

FWBI Entero Therapeutics, Inc.
2.9600
+4.59%
 
ADTX Aditxt, Inc.
2.0700
-1.90%
 
KPRX Kiora Pharmaceuticals, Inc.
0.5328
+0.23%
 
VRAX Virax Biolabs Group Limited
0.8330
-3.14%
 
ENSC Ensysce Biosciences, Inc.
0.5888
-7.16%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.7201
-5.24%
 
NRBO NeuroBo Pharmaceuticals, Inc.
3.9750
-8.41%
 
PXMD PaxMedica, Inc.
0.2750
-8.33%
 
SPRC SciSparc Ltd.
1.1600
-1.69%
 
REVB Revelation Biosciences, Inc.
1.9100
-5.45%